Affimed Therapeutics

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

Affimed Therapeutics AG, a biopharmaceutical company, engages in the discovery and development of recombinant antibody therapeutics for the treatment of cancer and other diseases. It offers TandAbs, a tetravalent antibody that is targeting tumor cells. The company also provides programs for treatment of Non-Hodgkin's Lymphoma, Hodgkin's diseases, thrombosis and autoimmune, leukemia, myeloma, solid tumors, metastasis, non-cancer indications, allergy, and asthma diseases. Affimed Therapeutics AG was founded in 2000 and is headquartered in Heidelberg, Germany.